Your browser doesn't support javascript.
loading
The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation.
Edman, Karl; Ahlgren, Ragnhild; Bengtsson, Malena; Bladh, Håkan; Bäckström, Stefan; Dahmén, Jan; Henriksson, Krister; Hillertz, Per; Hulikal, Vijakumar; Jerre, Anders; Kinchin, Liz; Kåse, Charlotte; Lepistö, Matti; Mile, Irene; Nilsson, Stinabritt; Smailagic, Amir; Taylor, John; Tjörnebo, Ann; Wissler, Lisa; Hansson, Thomas.
Afiliación
  • Edman K; Discovery Sciences, Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
  • Ahlgren R; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Bengtsson M; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Bladh H; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Bäckström S; Discovery Sciences, Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
  • Dahmén J; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Henriksson K; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Hillertz P; Discovery Sciences, Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
  • Hulikal V; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Jerre A; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Kinchin L; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Kåse C; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Lepistö M; Respiratory, Inflammation and Autoimmunity, Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
  • Mile I; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Nilsson S; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Smailagic A; Respiratory, Inflammation and Autoimmunity, Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
  • Taylor J; Respiratory, Inflammation and Autoimmunity, Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
  • Tjörnebo A; AstraZeneca R&D Lund, Scheelevägen 1, SE-221 87 Lund, Sweden.
  • Wissler L; Discovery Sciences, Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
  • Hansson T; Respiratory, Inflammation and Autoimmunity, Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden. Electronic address: thomas.g.hansson@astrazeneca.com.
Bioorg Med Chem Lett ; 24(11): 2571-7, 2014 Jun 01.
Article en En | MEDLINE | ID: mdl-24755427

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Receptores de Glucocorticoides / Antiinflamatorios no Esteroideos / Descubrimiento de Drogas Límite: Humans Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2014 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Receptores de Glucocorticoides / Antiinflamatorios no Esteroideos / Descubrimiento de Drogas Límite: Humans Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2014 Tipo del documento: Article País de afiliación: Suecia